GlucoTrack, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $2.1M
- Price
- $0.3416
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.06%
- Volume
- 532.4K
About
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
Quick stats
Shares outstanding6.3M
Computed float6.2M
Float / shares99.6%
Key info
SectorHealthcare
IndustryMedical - Instruments & Supplies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001506983
Websitehttps://www.glucotrack.com
AI Summary
AI-generated1/25
standardbullishother
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
Glucotrack regained compliance with Nasdaq's stockholders' equity requirement and has been granted continued listing on the exchange by the Nasdaq Hearings Panel.
CEO Erik Emerson stated the decision acknowledges substantial progress in repositioning the company and strengthening its financial foundation for long-term growth.
The company currently operates through the Lōkahi Therapeutics biopharmaceutical platform and its Glucotrack Technologies subsidiary, which is developing a continuous blood glucose monitoring system.
Red flags
- Listing granted subject to certain conditions
- Glucotrack CBGM device is limited to investigational use